Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2

Study acronym: PENFS
StatusNot Yet Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion moved earlier from Aug 2029 to Feb 2029 Show 5 more changesShow less
    • Eligibility criteria expanded, about 34 words
    • Secondary endpoints: 3 to 5
    • Study description expanded, about 326 words
    • Site contact updated
    • Publications: details revised at 13 of 15 entries
  2. Primary completion pushed from Feb 2027 to Feb 2029
    • Start date: Feb 10, 2026 to Feb 10, 2027
    • Study completion pushed from Aug 2027 to Aug 2029
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Primary completion date: Jan 2026 to Feb 2027v2 Show 6 more changesShow less
    • Start date: Jan 2025 to Feb 10, 2026
    • Study completion date: Jan 2026 to Aug 2027
    • Interventions: PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION (Device) to PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION (Device), Sham percutaneous electrical nerve field stimulation (Device)
    • Eligibility criteria shortened, about 9 words
    • Site contact updated
    • Study title shortened, about 3 words
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Indiana University
313 trials monitored
See 44 trials at risk
Diabetes
5,101 trials monitored
See 233 trials at risk
The purpose of this study is to evaluate whether stimulation of the vagus nerve can improve nausea and vomiting in diabetic gastroparetic patients.
Trial Details
NCT Number NCT06783504
Lead Sponsor Indiana University
Conditions
(from sponsor)		 Diabetes, Gastroparesis
Related terms Diabetes Mellitus, Gastroparesis
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov